• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.硼替佐米的引入对肾功能损害的多发性骨髓瘤患者透析独立性的影响：一项基于荷兰全国人口的研究。
Haematologica. 2018 Jul;103(7):e311-e314. doi: 10.3324/haematol.2017.184754. Epub 2018 Mar 15.
2
A population-based study of the impact of dialysis on mortality in multiple myeloma.一项基于人群的关于透析对多发性骨髓瘤死亡率影响的研究。
Br J Haematol. 2018 Feb;180(4):588-591. doi: 10.1111/bjh.14394. Epub 2016 Oct 21.
3
Dialysis Independence Following Combination Daratumumab, Thalidomide, Bortezomib, Cyclophosphamide, and Dexamethasone in Multiple Myeloma With Severe Renal Failure.达雷妥尤单抗、沙利度胺、硼替佐米、环磷酰胺和地塞米松联合治疗严重肾衰竭多发性骨髓瘤后的透析独立性
Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e395-e398. doi: 10.1016/j.clml.2020.03.014. Epub 2020 Apr 7.
4
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma.达雷妥尤单抗在多发性骨髓瘤继发的透析依赖型肾衰竭中的安全性和有效性。
Haematologica. 2018 Jun;103(6):e277-e278. doi: 10.3324/haematol.2018.191122. Epub 2018 Apr 5.
5
Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014.多发性骨髓瘤治疗的演变及其对透析独立性的影响：来自法国1999年至2014年队列的数据。
Blood Cancer J. 2016 Mar 25;6(3):e409. doi: 10.1038/bcj.2016.17.
6
Bortezomib-based treatment for multiple myeloma patients with renal impairment: A systematic review and meta-analysis of observational studies.基于硼替佐米的肾功能损害多发性骨髓瘤患者治疗：观察性研究的系统评价和荟萃分析
Medicine (Baltimore). 2016 Nov;95(46):e5202. doi: 10.1097/MD.0000000000005202.
7
Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.复发多发性骨髓瘤患者皮下注射与静脉注射硼替佐米的比较：III期MMY-3021研究中肾功能损害患者的亚组分析
Haematologica. 2015 May;100(5):e207-10. doi: 10.3324/haematol.2014.118182. Epub 2015 Jan 16.
8
Outcome of patients with multiple myeloma and renal failure on novel regimens.采用新方案治疗的多发性骨髓瘤合并肾衰竭患者的治疗结果。
Saudi J Kidney Dis Transpl. 2016 Mar;27(2):335-40. doi: 10.4103/1319-2442.178557.
9
Clinical features and treatment outcome of elderly multiple myeloma patients with impaired renal function.肾功能受损的老年多发性骨髓瘤患者的临床特征和治疗结果。
J Clin Lab Anal. 2019 Jun;33(5):e22888. doi: 10.1002/jcla.22888. Epub 2019 Apr 19.
10
[A clinical analysis of 69 newly diagnosed multiple myeloma patients with renal insufficiency].69例新诊断的合并肾功能不全的多发性骨髓瘤患者的临床分析
Zhonghua Nei Ke Za Zhi. 2016 Oct 1;55(10):764-768. doi: 10.3760/cma.j.issn.0578-1426.2016.10.008.

引用本文的文献

1
Dialysis dependence is associated with poor prognosis in multiple myeloma: a multicenter retrospective cohort study.透析依赖与多发性骨髓瘤的不良预后相关：一项多中心回顾性队列研究。
Ther Adv Med Oncol. 2025 Aug 21;17:17588359251357682. doi: 10.1177/17588359251357682. eCollection 2025.
2
Impact of dialysis dependence on survival for multiple myeloma with renal impairment: a multicenter study in China.透析依赖对合并肾功能损害的多发性骨髓瘤患者生存的影响：一项中国多中心研究
Am J Cancer Res. 2023 Apr 15;13(4):1571-1581. eCollection 2023.
3
Activation of ER Stress-Dependent miR-216b Has a Critical Role in Ethanol-Extract-Induced Apoptosis in U266 and U937 Cells.内质网应激依赖性 miR-216b 的激活在乙醇提取物诱导的 U266 和 U937 细胞凋亡中起关键作用。
Int J Mol Sci. 2018 Apr 19;19(4):1240. doi: 10.3390/ijms19041240.

本文引用的文献

1
Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study.新诊断多发性骨髓瘤患者肾功能的恢复与生存率提高无关：一项基于人群的研究。
Leuk Lymphoma. 2017 Sep;58(9):1-9. doi: 10.1080/10428194.2016.1277385. Epub 2017 Feb 14.
2
A population-based study of the impact of dialysis on mortality in multiple myeloma.一项基于人群的关于透析对多发性骨髓瘤死亡率影响的研究。
Br J Haematol. 2018 Feb;180(4):588-591. doi: 10.1111/bjh.14394. Epub 2016 Oct 21.
3
Evolution in the treatment of multiple myeloma and impact on dialysis independence: data from a French cohort from 1999 to 2014.多发性骨髓瘤治疗的演变及其对透析独立性的影响：来自法国1999年至2014年队列的数据。
Blood Cancer J. 2016 Mar 25;6(3):e409. doi: 10.1038/bcj.2016.17.
4
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment.国际骨髓瘤工作组关于骨髓瘤相关肾脏损害的诊断和管理建议。
J Clin Oncol. 2016 May 1;34(13):1544-57. doi: 10.1200/JCO.2015.65.0044. Epub 2016 Mar 14.
5
Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.接受长期透析的多发性骨髓瘤或轻链淀粉样变性患者的生存及肾脏恢复趋势
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):431-41. doi: 10.2215/CJN.06290615. Epub 2016 Jan 4.
6
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.新型药物在新诊断为多发性骨髓瘤的有症状患者肾功能损害可逆性中的作用。
Leukemia. 2013 Feb;27(2):423-9. doi: 10.1038/leu.2012.182. Epub 2012 Jul 5.
7
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.多发性骨髓瘤患者的肾功能损害：国际骨髓瘤工作组的共识声明。
J Clin Oncol. 2010 Nov 20;28(33):4976-84. doi: 10.1200/JCO.2010.30.8791. Epub 2010 Oct 18.
8
Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.多发性骨髓瘤或轻链沉积病导致终末期肾病开始肾脏替代治疗患者的发病率和结局：ERA-EDTA 登记研究。
Nephrol Dial Transplant. 2010 Apr;25(4):1200-6. doi: 10.1093/ndt/gfp679. Epub 2009 Dec 27.
9
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.接受基于硼替佐米方案治疗的多发性骨髓瘤患者肾功能损害的可逆性：预测因素的识别
Clin Lymphoma Myeloma. 2009 Aug;9(4):302-6. doi: 10.3816/CLM.2009.n.059.
10
Pathogenesis and treatment of renal failure in multiple myeloma.多发性骨髓瘤肾衰竭的发病机制与治疗
Leukemia. 2008 Aug;22(8):1485-93. doi: 10.1038/leu.2008.131. Epub 2008 Jun 5.

The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.

作者信息

Oortgiesen Berdien E, Azad Roshna, Hemmelder Marc H, Kibbelaar Robby E, Veeger Nic J G M, de Vries Joost C, van Roon Eric N, Hoogendoorn Mels

机构信息

Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, the Netherlands

Department of Clinical Pharmacy and Pharmacology, Medical Center Leeuwarden, the Netherlands.

出版信息

Haematologica. 2018 Jul;103(7):e311-e314. doi: 10.3324/haematol.2017.184754. Epub 2018 Mar 15.

DOI:10.3324/haematol.2017.184754
PMID:29545339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6029552/
Abstract
摘要